Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P Pedro Granadillo


  • Director at Health Sciences Acquisitions Corp (HSAC), 2019-05-10
  • at Rocket Pharmaceuticals Inc. (RCKT), 2019-01-30
  • Director at Haemonetics Corp (HAE), 2018-11-09
  • Director at Nps Pharmaceuticals Inc (NPSP), 2015-02-25
  • Director at Dendreon Corp (DNDN), 2014-01-07
  • Director at Nile Therapeutics Inc. (NLTX), 2011-05-12
  • Director at Noven Pharmaceuticals Inc (NOVN), 2009-08-27
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
HAE $114.50 12,322 Director 15,335 2018-11-08 Filing
HAE $114.16 631 Director 27,657 2018-09-17 Filing
HAE $113.16 11,812 Director 28,288 2018-09-17 Filing
HAE $111.33 13,183 Director 40,100 2018-09-17 Filing
HAE $110.11 3,696 Director 53,283 2018-09-17 Filing